Galapagos expands and extends drug discovery collaboration with Amgen into 2008(01/04/2007) Galapagos NV announced that its service division BioFocus DPI has expanded and extended its longstanding drug discovery collaboration with Amgen through 2007 and 2008. BioFocus DPI will continue to provide biology, computational and medicinal ...
Galapagos and The ALS Association announce EUR2.4 million target discovery alliance(12/12/2006) Galapagos NV and The ALS Association, a non-profit health organization dedicated to finding a cure for amyotrophic lateral sclerosis (ALS), announced a new two-year target discovery alliance. Galapagos' service division BioFocus DPI will apply its ...
Galapagos and Cellzome in kinase drug discovery collaboration(07/20/2006) Galapagos NV and Cellzome Inc. have announced that they are collaborating in kinase drug discovery. Under the terms of the agreement, Galapagos' service division BioFocus DPI gives Cellzome access to its SoftFocus® kinase libraries and provides ...
Galapagos and Arthrogen enter target discovery alliance(04/03/2006) Galapagos NV announced that its service division BioFocus has entered into a three-year target discovery alliance with Arthrogen BV, a joint venture of the Dubai Bone & Joint Center and the Academic Medical Center in Amsterdam. The alliance focuses ...
Top
analytica
analytica China
analytica Vietnam
analytica Anacon